Joel Salinas is a Neurology physician affiliated with New York University. OpenAlex indexes 65 publications with 1,324 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
145 E 32nd St Fl 2
New York, NY 100166055
Telephone
212-263-3210Provider last certified this registry record 17 Nov 2022.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year202548 payments$60,794openpaymentsdata.cms.gov ↗
- Lilly USA, LLCProgram year202443 payments$49,578openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Cholinesterase Inhibitor42.1%Donepezil Hcl71%Rivastigmine18%Galantamine Hbr11%Part D<11 patientsSSRI25.9%Citalopram Hbr48%Escitalopram Oxalate36%Trazodone Hcl16%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:
- Identifying ADRD intervention targets by characterizing neurobiological mechanisms of social isolation, loneliness, and social environment using novel imaging, molecular markers, and machine learning
New York University School of Medicine
FY2026$667,131R01AG079282 - Identifying ADRD intervention targets by characterizing neurobiological mechanisms of social isolation, loneliness, and social environment using novel imaging, molecular markers, and machine learning
New York University School of Medicine
FY2025$653,789R01AG079282 - Identifying ADRD intervention targets by characterizing neurobiological mechanisms of social isolation, loneliness, and social environment using novel imaging, molecular markers, and machine learning
New York University School of Medicine
FY2024$667,131R01AG079282
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Early clinical outcomes following lecanemab therapy for mild cognitive impairment and mild dementia due to Alzheimer's disease
Journal of the Neurological Sciences
2025 - Association between dietary inflammatory index score and incident dementia
Alzheimer s & Dementia
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Galetta, MD
New York University
Herbert Lepor, MD
New York University
Aasma Shaukat, MD
New York University
Jerry Shapiro, MD
New York University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”